Z. Tong

发表

Development, Validation and Comparison of Artificial Neural Network Models and Logistic Regression Models Predicting Survival of Unresectable Pancreatic Cancer

Shuiguang Deng, P. Zhao, Jindi Zhang, 2020, Frontiers in Bioengineering and Biotechnology.

Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy

P. Zhao, W. Fang, Wei Wu, 2020, Journal for ImmunoTherapy of Cancer.

Changes in serum thymidine kinase 1 levels during chemotherapy correlate with objective response in patients with advanced gastric cancer.

Y. Ling, Yongping Liu, Z. Tong, 2011, Experimental and therapeutic medicine.

Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab

P. Zhao, W. Fang, Liyun Yuan, 2020, BMC Cancer.

Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?

P. Zhao, W. Fang, Wei Wu, 2019, World journal of clinical cases.

A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin

P. Zhao, W. Fang, Weilin Wang, 2018, British Journal of Cancer.

Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab

P. Zhao, W. Fang, Liyun Yuan, 2020, BMC Cancer.

Development and validation of a meta-learning-based multi-modal deep learning algorithm for detection of peritoneal metastasis

P. Zhao, W. Fang, Q. Fu, 2022, International Journal of Computer Assisted Radiology and Surgery.

S-1/temozolomide versus S-1/temozolomide plus thalidomide in advanced pancreatic and non-pancreatic neuroendocrine tumours (STEM): A randomised, open-label, multicentre phase 2 trial

W. Fang, Xiaofei Yan, Hong Zhao, 2022, EClinicalMedicine.

412 CAMrelizumab and apatiniB combIned with chemoTherapy (mFOLFOX6) as neoadjuvant therapy for locally advanced rIght-sided colON cancer (AMBITION)

W. Fang, Xiao-xiao Cheng, Fanlong Liu, 2021, Journal for ImmunoTherapy of Cancer.

Development and validation of a meta-learning-based multi-modal deep learning algorithm for detection of peritoneal metastasis

P. Zhao, W. Fang, Q. Fu, 2022, International Journal of Computer Assisted Radiology and Surgery.

Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma

P. Zhao, W. Fang, Q. Fu, 2021, Theranostics.

Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review

P. Zhao, W. Fang, Bin Li, 2020, Frontiers in Immunology.

Large-scale identification of extracellular plant miRNAs in mammals implicates their dietary intake

W. Fang, M. Timko, L. Fan, 2021, PloS one.

Depiction of the genomic and genetic landscape identifies CCL5 as a protective factor in colorectal neuroendocrine carcinoma

P. Zhao, W. Fang, Xiao-xiao Cheng, 2021, British Journal of Cancer.

A naive Bayes algorithm for tissue origin diagnosis (TOD‐Bayes) of synchronous multifocal tumors in the hepatobiliary and pancreatic system

Xingchen Zhang, Longjiang Fan, Linfu Zhou, 2018, International journal of cancer.

Carcinoma of Unknown Primary with EML4-ALK Fusion Response to ALK Inhibitors.

P. Zhao, W. Fang, Wei Wu, 2019, The oncologist.

Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy

W. Fang, Junwei Liu, Weiwei Yin, 2022, Journal for ImmunoTherapy of Cancer.

Oxaliplatin plus irinotecan vs irinotecan as second-line treatment in pancreatic cancer patients: a randomized–controlled open-label Phase II study

P. Zhao, W. Fang, Q. Fu, 2022, Gastroenterology report.

Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma

P. Zhao, W. Fang, Q. Fu, 2021, Cancer Immunology, Immunotherapy.

Identifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms

P. Zhao, W. Fang, L. Fan, 2016, Oncotarget.

Clostridium difficile colonization in preoperative colorectal cancer patients

P. Zhao, W. Fang, Yun Luo, 2017, Oncotarget.

A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin

P. Zhao, W. Fang, Weilin Wang, 2018, British Journal of Cancer.

Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study

P. Zhao, W. Fang, W. Jiang, 2017, World Journal of Surgical Oncology.

Nutrition and metabolism status alteration in advanced hepatocellular carcinoma patients treated with anti-PD-1 immunotherapy

P. Zhao, W. Fang, Shuwen Han, 2020, Supportive Care in Cancer.

Neuroendocrine Differentiation Is a Prognostic Factor for Stage II Poorly Differentiated Colorectal Cancer

Jinghong Xu, Q. Xiao, K. Ding, 2014, BioMed research international.

An immunometabolism subtyping system identifies S100A9+ macrophage as an immune therapeutic target in colorectal cancer based on multiomics analysis

Xin Li, P. Zhao, W. Fang, 2023, Cell reports. Medicine.

Retrospective pilot study of regorafenib combined with ICIs in the third-line treatment of advanced colorectal cancer.

P. Zhao, W. Fang, Q. Fu, 2021 .

Whole-exome sequencing reveals potential mechanisms of drug resistance to FGFR3-TACC3 targeted therapy and subsequent drug selection: towards a personalized medicine

Yu-An Dong, P. Zhao, W. Fang, 2020, BMC medical genomics.

Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients1

W. Fang, M. Yao, Z. Tong, 2018, Translational oncology.

Whole-exome sequencing reveals potential mechanisms of drug resistance to FGFR3-TACC3 targeted therapy and subsequent drug selection: towards a personalized medicine

Yu-An Dong, P. Zhao, W. Fang, 2020, BMC Medical Genomics.

Clonal Evolution Dynamics in Primary and Metastatic Lesions of Pancreatic Neuroendocrine Neoplasms

Lin Wang, P. Zhao, W. Fang, 2021, Frontiers in Medicine.

Expression of Presenilin-2 and Glutathione S Transferase π and Their Clinical Significance in Breast Infiltrating Ductal Carcinoma

H. Xiong, Z. Tong, Wu Xiaoting, 2005 .

Phase I trial of fourth-generation chimeric antigen receptor T-cells targeting glypican-3 for advanced hepatocellular carcinoma.

T. Liang, P. Zhao, W. Fang, 2021 .

NKG2D discriminates diverse ligands through selectively mechano‐regulated ligand conformational changes

W. Fang, J. Lou, Jin Zhang, 2021, The EMBO journal.

RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trial

Z. Liu, T. Liang, W. Fang, 2023, EClinicalMedicine.

Hydroquinone‐induced skin irritant reaction could be achieved by activating mast cells via mas‐related G protein–coupled receptor X2

D. Che, Z. Tong, B. Peng, 2022, Experimental dermatology.

Residual refinement for interactive skin lesion segmentation

Yin Wang, Feng Zhou, Hongtao Ma, 2021, Journal of Biomedical Semantics.

Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment.

Wei Wu, Z. Tong, Yuzhi Jin, 2024, Biomaterials.

The long-term effectiveness and mechanism of oncolytic virotherapy combined with anti-PD-L1 antibody in colorectal cancer patient.

Z. Tong, Yi Zheng, Lulu Liu, 2024, Cancer gene therapy.

S100A9+CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function

Z. Tong, Yi Zheng, Lulu Liu, 2024, Journal of experimental & clinical cancer research : CR.